Integrated Evidence Generation Strategy

Long-Range Planning for Improved Alignment and Efficiency 

Biopharma companies have long relied on planning exercises to help inform their product development process. But traditional approaches have their challenges. Short-term objectives that are aligned to budget cycles and functional area silos can lead to evidence gaps, duplication, inefficiency, and a lack of focus. 

Let our team help you develop differently. An Integrated Evidence Generation (IEG) Planning approach takes a long-term view and brings evidence generation strategies into alignment across functions and geographies. Consolidating plans to form an asset-level IEG plan can help you minimize development time and costs, avoid duplication of efforts, and promote technical, regulatory, and commercial collaboration in pursuit of optimizing patient outcomes.